NUVB vs RXRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

NUVB

57.4
AI Score
VS
NUVB Wins

RXRX

50.4
AI Score

Investment Advisor Scores

NUVB

57score
Recommendation
HOLD

RXRX

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NUVB RXRX Winner
Revenue 159.87M 32.69M NUVB
Net Income -99.34M -367.55M NUVB
Net Margin -62.1% -1124.2% NUVB
Operating Income -89.36M -386.65M NUVB
ROE -43.6% -40.6% RXRX
ROA -12.8% -30.1% NUVB
Total Assets 778.39M 1.22B RXRX
Cash 153.77M 549.85M RXRX
Current Ratio 7.45 5.01 NUVB

Relative Price Performance (Last 90 Days)

NUVB 1M: -9.1% · 3M: -29.7% RXRX 1M: -6.4% · 3M: +8.5%

Current Technical Phase

NUVB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.8%), weak momentum, RSI 38

RSI (14): 37.9 · Price: $4.29

RXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.1 · Price: $3.59

Fundamentals Snapshot

Metric NUVB RXRX
Market Cap — —
Forward P/E -36.2 -4.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 2.4% 2.6%
Gross Margin 0.9% -5.2%
Operating Margin -0.9% -6.6%
EPS -0.39 -0.86
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NUVB is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.